Clinical Trials Logo

Vitamin c clinical trials

View clinical trials related to Vitamin c.

Filter by:
  • None
  • Page 1

NCT ID: NCT05770596 Recruiting - Clinical trials for Post-mastectomy Pain Syndrome

Vitamin C on Acute and Chronic Post Mastectomy Pain

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

This prospective randomized double-blinded controlled study will be conducted to evaluate the effect of perioperative vitamin C on acute and chronic post mastectomy pain after breast cancer surgery

NCT ID: NCT05694975 Recruiting - COVID-19 Pneumonia Clinical Trials

Efficacy of Megadose Vitamin C in Severe and Critical Ill COVID-19 Patients.

Start date: January 13, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The main aim is to determine whether vitamin C can reduce 28-day all-cause mortality or persistent organ dysfunction compared with placebo in patients with severe and critical ill COVID-19 patients. Participants will randomly receive HIVC or placebo for 4 days once enrolled. The primary outcome is a composite of death or persistent organ dysfunction (defined as dependency on vasopressors, mechanical ventilation, or CRRT) at day 28 after randomization.

NCT ID: NCT04516681 Recruiting - Colorectal Cancer Clinical Trials

IV Ascorbic Acid in Peritoneal Metastatic Colorectal Cancer

Start date: September 1, 2020
Phase: Phase 3
Study type: Interventional

Previous preclinical study has shown that high levels of ascorbic acid (AA) possesses the ability to kill human colorectal cancer cells and high expression of GLUT3 will augment the efficacy of AA. To date, no previous studies have investigated the therapeutic role of AA in peritoneal metastatic colorectal cancer with high expression of GLUT3. This protocol is a randomized controlled study of AA infusions combined with FOLFOXIRI +/- bevacizumab versus treatment with FOLFOXIRI +/- bevacizumab alone in peritoneal metastatic colorectal cancer patients with high expression of GLUT3.

NCT ID: NCT04401150 Completed - COVID-19 Clinical Trials

Lessening Organ Dysfunction With VITamin C - COVID-19

LOVIT-COVID
Start date: August 14, 2020
Phase: Phase 3
Study type: Interventional

LOVIT-COVID is a multicentre concealed-allocation parallel-group blinded randomized controlled trial to ascertain the effect of high-dose intravenous vitamin C compared to placebo on mortality or persistent organ dysfunction at 28 days in hospitalized COVID-19 patients.

NCT ID: NCT04264533 Terminated - Pneumonia, Viral Clinical Trials

Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia

Start date: February 14, 2020
Phase: Phase 2
Study type: Interventional

2019 new coronavirus (2019-nCoV) infected pneumonia, namely severe acute respiratory infection (SARI) has caused global concern and emergency. There is a lack of effective targeted antiviral drugs, and symptomatic supportive treatment is still the current main treatment for SARI. Vitamin C is significant to human body and plays a role in reducing inflammatory response and preventing common cold. In addtion, a few studies have shown that vitamin C deficiency is related to the increased risk and severity of influenza infections. We hypothize that Vitamin C infusion can help improve the prognosis of patients with SARI. Therefore, it is necessary to study the clinical efficacy and safety of vitamin C for the clinical management of SARI through randomized controlled trials during the current epidemic of SARI.

NCT ID: NCT04046861 Not yet recruiting - Cardiac Disease Clinical Trials

Influence of High Vitamin C Dose on Lactate During and After Extracorporeal Circulation

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The aim of our study is to find out whether high doses of vitamin C before cardiopulmonary bypass and during the first 24 hours after that have and impact of lowering the incidence of hyperlactatemia.

NCT ID: NCT03680274 Completed - COVID-19 Clinical Trials

Lessening Organ Dysfunction With VITamin C

LOVIT
Start date: November 8, 2018
Phase: Phase 3
Study type: Interventional

LOVIT is a multicentre concealed-allocation parallel-group blinded randomized controlled trial to ascertain the effect of high-dose intravenous vitamin C compared to placebo on mortality or persistent organ dysfunction at 28 days in septic intensive care unit patients. Patients with COVID-19 are considered eligible for this study.

NCT ID: NCT02083575 Not yet recruiting - Thalassemia Major Clinical Trials

Role of Vitamin C to Augment Iron Chelation With DFP or DFX

Start date: April 2014
Phase: Phase 2/Phase 3
Study type: Interventional

role of Vit C to Augment iron chelation with DFP or DFX in thalassemic patients.